

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 6.15349964 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.85259217 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.80579918 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.71003897 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.61858487 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 5.52774392 |
| 7 | protein localization to synapse (GO:0035418) | 5.41166125 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.24409660 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.22687615 |
| 10 | glutamate secretion (GO:0014047) | 5.04497726 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.88488513 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.85354759 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.81551932 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.75732099 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.74198746 |
| 16 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.69105287 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.66215955 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.61883805 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.61637624 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.54623935 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.46442281 |
| 22 | positive regulation of synapse maturation (GO:0090129) | 4.45159779 |
| 23 | exploration behavior (GO:0035640) | 4.38267112 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38008031 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.37573145 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.37112697 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.33940410 |
| 28 | positive regulation of action potential (GO:0045760) | 4.25620077 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.17299617 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.15751988 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.13041134 |
| 32 | nucleobase catabolic process (GO:0046113) | 4.05385736 |
| 33 | presynaptic membrane assembly (GO:0097105) | 4.04888690 |
| 34 | negative regulation of dendrite development (GO:2000171) | 3.96170638 |
| 35 | neuron recognition (GO:0008038) | 3.95114339 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.94951729 |
| 37 | postsynaptic membrane organization (GO:0001941) | 3.94102798 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.92894156 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.90748628 |
| 40 | long-term memory (GO:0007616) | 3.85276203 |
| 41 | layer formation in cerebral cortex (GO:0021819) | 3.83914949 |
| 42 | membrane depolarization during action potential (GO:0086010) | 3.82908903 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.82682395 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.82602981 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.78838953 |
| 46 | response to histamine (GO:0034776) | 3.78570148 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.76917336 |
| 48 | presynaptic membrane organization (GO:0097090) | 3.74177438 |
| 49 | regulation of synaptic plasticity (GO:0048167) | 3.73136085 |
| 50 | auditory behavior (GO:0031223) | 3.71204840 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.70159255 |
| 52 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.68794147 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67287490 |
| 54 | regulation of glutamate secretion (GO:0014048) | 3.65945841 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64845649 |
| 56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.59343867 |
| 57 | axonal fasciculation (GO:0007413) | 3.59339391 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.57836840 |
| 59 | neurotransmitter transport (GO:0006836) | 3.56555888 |
| 60 | cell migration in hindbrain (GO:0021535) | 3.53878716 |
| 61 | behavioral response to cocaine (GO:0048148) | 3.52954119 |
| 62 | transmission of nerve impulse (GO:0019226) | 3.52052273 |
| 63 | behavioral response to nicotine (GO:0035095) | 3.46851061 |
| 64 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.46780770 |
| 65 | regulation of synapse maturation (GO:0090128) | 3.46345317 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.41727167 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.41601183 |
| 68 | proline transport (GO:0015824) | 3.36324150 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.36079617 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.33166151 |
| 71 | response to auditory stimulus (GO:0010996) | 3.32956853 |
| 72 | regulation of dendritic spine development (GO:0060998) | 3.32534260 |
| 73 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31969844 |
| 74 | regulation of female receptivity (GO:0045924) | 3.30289575 |
| 75 | behavioral fear response (GO:0001662) | 3.29816336 |
| 76 | behavioral defense response (GO:0002209) | 3.29816336 |
| 77 | learning (GO:0007612) | 3.28736529 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28050920 |
| 79 | membrane depolarization (GO:0051899) | 3.28016104 |
| 80 | regulation of vesicle fusion (GO:0031338) | 3.27576438 |
| 81 | neuronal action potential (GO:0019228) | 3.27484993 |
| 82 | regulation of neurotransmitter secretion (GO:0046928) | 3.27185263 |
| 83 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.26866795 |
| 84 | mechanosensory behavior (GO:0007638) | 3.23764674 |
| 85 | response to pheromone (GO:0019236) | 3.22111792 |
| 86 | regulation of action potential (GO:0098900) | 3.21666353 |
| 87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.21570666 |
| 88 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.18734197 |
| 89 | cerebellar granule cell differentiation (GO:0021707) | 3.17528637 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.16843977 |
| 91 | female mating behavior (GO:0060180) | 3.16388957 |
| 92 | startle response (GO:0001964) | 3.16170468 |
| 93 | positive regulation of dendritic spine development (GO:0060999) | 3.14164966 |
| 94 | fear response (GO:0042596) | 3.13967871 |
| 95 | striatum development (GO:0021756) | 3.13701680 |
| 96 | synapse assembly (GO:0007416) | 3.12899564 |
| 97 | neuromuscular process controlling balance (GO:0050885) | 3.12525110 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.09714081 |
| 99 | serotonin metabolic process (GO:0042428) | 3.09385484 |
| 100 | intraspecies interaction between organisms (GO:0051703) | 3.08673342 |
| 101 | social behavior (GO:0035176) | 3.08673342 |
| 102 | cellular potassium ion homeostasis (GO:0030007) | 3.07984698 |
| 103 | negative regulation of amino acid transport (GO:0051956) | 3.06455034 |
| 104 | positive regulation of synapse assembly (GO:0051965) | 3.03744316 |
| 105 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03655679 |
| 106 | regulation of neurotransmitter transport (GO:0051588) | 3.02988396 |
| 107 | activation of protein kinase A activity (GO:0034199) | 3.02333470 |
| 108 | prepulse inhibition (GO:0060134) | 3.02260064 |
| 109 | regulation of synaptic transmission (GO:0050804) | 3.02208984 |
| 110 | synaptic transmission (GO:0007268) | 3.01210110 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.00590561 |
| 112 | synaptic transmission, dopaminergic (GO:0001963) | 2.99204593 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.98489126 |
| 114 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.97664985 |
| 115 | detection of calcium ion (GO:0005513) | 2.96384400 |
| 116 | neurofilament cytoskeleton organization (GO:0060052) | 2.96239813 |
| 117 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95542429 |
| 118 | righting reflex (GO:0060013) | 2.95008698 |
| 119 | primary amino compound metabolic process (GO:1901160) | 2.94045753 |
| 120 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.93787769 |
| 121 | detection of light stimulus involved in visual perception (GO:0050908) | 2.93787769 |
| 122 | glycosphingolipid biosynthetic process (GO:0006688) | 2.88344222 |
| 123 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.84172027 |
| 124 | establishment of mitochondrion localization (GO:0051654) | 2.84102221 |
| 125 | tachykinin receptor signaling pathway (GO:0007217) | 2.82934807 |
| 126 | neuronal ion channel clustering (GO:0045161) | 2.82517249 |
| 127 | adult walking behavior (GO:0007628) | 2.82452896 |
| 128 | regulation of respiratory system process (GO:0044065) | 2.80625650 |
| 129 | action potential (GO:0001508) | 2.78578720 |
| 130 | C4-dicarboxylate transport (GO:0015740) | 2.74720143 |
| 131 | urinary tract smooth muscle contraction (GO:0014848) | 2.72756495 |
| 132 | glycerophospholipid catabolic process (GO:0046475) | 2.72074436 |
| 133 | adult behavior (GO:0030534) | 2.71793299 |
| 134 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70530360 |
| 135 | response to amphetamine (GO:0001975) | 2.70173080 |
| 136 | neurotransmitter uptake (GO:0001504) | 2.69454066 |
| 137 | behavioral response to ethanol (GO:0048149) | 2.67800357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.47008847 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06729029 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24841131 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17024950 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12262325 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70688359 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69688364 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66716757 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66716757 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62484753 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59908792 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53894979 |
| 13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52259205 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51740765 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47483115 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47074223 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30394115 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.27096821 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24126110 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20759481 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20409048 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20114325 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14809679 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14228371 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09495679 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08859206 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08521422 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03695012 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01795769 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00646920 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85106783 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83018307 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73821189 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71340489 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70908422 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68771808 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60199914 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.59188346 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49723607 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49142697 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48321010 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46212958 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44088950 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42244814 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41376857 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39882971 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38760893 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37394187 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36726380 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36303756 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35650503 |
| 52 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33921325 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33294689 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32983247 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32950518 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32101720 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.31610793 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31230219 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30647454 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30647454 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29962426 |
| 62 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27767401 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26475955 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26269438 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25514147 |
| 66 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25386889 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.24654454 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24128291 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22147891 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19375339 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19209132 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18021048 |
| 73 | AR_19668381_ChIP-Seq_PC3_Human | 1.15043633 |
| 74 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.13910794 |
| 75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13777986 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13751444 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13728152 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13377476 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13269154 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10289387 |
| 81 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09752480 |
| 82 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09413428 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09102590 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08833039 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08713790 |
| 86 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07459519 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07421935 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06139208 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05459911 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04950088 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04840992 |
| 92 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04642980 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04290776 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03329924 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03295791 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02692742 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02651929 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02572331 |
| 99 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01834856 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01283582 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00257266 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00107533 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00040616 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99440764 |
| 105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99042619 |
| 106 | * JUN_21703547_ChIP-Seq_K562_Human | 0.97749086 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96919054 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96481812 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95891356 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94954431 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94948848 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94426888 |
| 113 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93529928 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93041319 |
| 115 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92851663 |
| 116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88239237 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87668423 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87358376 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87358376 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86281250 |
| 121 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86251814 |
| 122 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86067009 |
| 123 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85958164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.38968247 |
| 2 | MP0003880_abnormal_central_pattern | 5.68512294 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.29479735 |
| 4 | MP0002822_catalepsy | 3.82359392 |
| 5 | MP0009745_abnormal_behavioral_response | 3.68134315 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.52370129 |
| 7 | MP0004270_analgesia | 3.51461224 |
| 8 | MP0002064_seizures | 3.26716078 |
| 9 | MP0009046_muscle_twitch | 3.16862974 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.10120362 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.99062062 |
| 12 | MP0002272_abnormal_nervous_system | 2.56418462 |
| 13 | MP0001486_abnormal_startle_reflex | 2.51524342 |
| 14 | MP0002736_abnormal_nociception_after | 2.51358504 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.45368879 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.42675345 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.39393080 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.33487144 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.19744076 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.15689567 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.06761409 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.01486655 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.00295139 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.92013269 |
| 25 | MP0001529_abnormal_vocalization | 1.91188663 |
| 26 | MP0001970_abnormal_pain_threshold | 1.88477137 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.86082027 |
| 28 | MP0004924_abnormal_behavior | 1.86082027 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.85156746 |
| 30 | MP0003329_amyloid_beta_deposits | 1.84802635 |
| 31 | MP0000778_abnormal_nervous_system | 1.84075181 |
| 32 | MP0001984_abnormal_olfaction | 1.81699238 |
| 33 | MP0002184_abnormal_innervation | 1.77182181 |
| 34 | MP0003879_abnormal_hair_cell | 1.67360177 |
| 35 | MP0008569_lethality_at_weaning | 1.66178052 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.63710493 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.61864568 |
| 38 | MP0001905_abnormal_dopamine_level | 1.56633666 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.51382251 |
| 40 | MP0002102_abnormal_ear_morphology | 1.47868594 |
| 41 | MP0003121_genomic_imprinting | 1.45394373 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.42380363 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.41136215 |
| 44 | MP0000955_abnormal_spinal_cord | 1.40579474 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.36111771 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.33556873 |
| 47 | MP0004858_abnormal_nervous_system | 1.33041502 |
| 48 | MP0001188_hyperpigmentation | 1.32774683 |
| 49 | MP0003787_abnormal_imprinting | 1.32229679 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.27247008 |
| 51 | MP0003633_abnormal_nervous_system | 1.26112359 |
| 52 | MP0004147_increased_porphyrin_level | 1.25311954 |
| 53 | MP0004142_abnormal_muscle_tone | 1.24048458 |
| 54 | MP0004885_abnormal_endolymph | 1.19590587 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.14361234 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.14286535 |
| 57 | MP0003631_nervous_system_phenotype | 1.11776955 |
| 58 | MP0002152_abnormal_brain_morphology | 1.08094311 |
| 59 | MP0008872_abnormal_physiological_respon | 1.06249248 |
| 60 | MP0003122_maternal_imprinting | 1.06194471 |
| 61 | MP0008874_decreased_physiological_sensi | 1.03918021 |
| 62 | MP0005253_abnormal_eye_physiology | 1.00179380 |
| 63 | MP0002234_abnormal_pharynx_morphology | 0.96888383 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 0.95113486 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.94774036 |
| 66 | MP0000751_myopathy | 0.93319264 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.93173288 |
| 68 | MP0004742_abnormal_vestibular_system | 0.90472629 |
| 69 | MP0005535_abnormal_body_temperature | 0.90426385 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.90260251 |
| 71 | MP0002229_neurodegeneration | 0.88307951 |
| 72 | MP0004133_heterotaxia | 0.88172918 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 0.87158313 |
| 74 | MP0000604_amyloidosis | 0.87089891 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.86155551 |
| 76 | MP0004085_abnormal_heartbeat | 0.84466816 |
| 77 | MP0002090_abnormal_vision | 0.84279427 |
| 78 | MP0005394_taste/olfaction_phenotype | 0.84222744 |
| 79 | MP0005499_abnormal_olfactory_system | 0.84222744 |
| 80 | MP0001963_abnormal_hearing_physiology | 0.83380695 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.82789243 |
| 82 | MP0001177_atelectasis | 0.82601453 |
| 83 | MP0006292_abnormal_olfactory_placode | 0.82258718 |
| 84 | MP0003632_abnormal_nervous_system | 0.78439887 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.76223174 |
| 86 | MP0002751_abnormal_autonomic_nervous | 0.75897514 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.75019374 |
| 88 | MP0004043_abnormal_pH_regulation | 0.74649383 |
| 89 | MP0000427_abnormal_hair_cycle | 0.73952319 |
| 90 | MP0003075_altered_response_to | 0.73884051 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.73693034 |
| 92 | MP0003011_delayed_dark_adaptation | 0.71998721 |
| 93 | MP0005409_darkened_coat_color | 0.71216146 |
| 94 | MP0001664_abnormal_digestion | 0.69931181 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69906546 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.68674006 |
| 97 | MP0002928_abnormal_bile_duct | 0.68012470 |
| 98 | MP0003634_abnormal_glial_cell | 0.67420841 |
| 99 | MP0003698_abnormal_male_reproductive | 0.66733095 |
| 100 | MP0005195_abnormal_posterior_eye | 0.66589878 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.66256623 |
| 102 | MP0004484_altered_response_of | 0.66002987 |
| 103 | MP0003646_muscle_fatigue | 0.65681070 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.64584742 |
| 105 | MP0003690_abnormal_glial_cell | 0.63833694 |
| 106 | MP0003119_abnormal_digestive_system | 0.63053322 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.61599059 |
| 108 | MP0002160_abnormal_reproductive_system | 0.59864808 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.58061925 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.57445269 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.57148377 |
| 112 | MP0000920_abnormal_myelination | 0.55309845 |
| 113 | MP0001943_abnormal_respiration | 0.54920330 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.54859497 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.51532463 |
| 116 | MP0010770_preweaning_lethality | 0.50799262 |
| 117 | MP0002082_postnatal_lethality | 0.50799262 |
| 118 | MP0005171_absent_coat_pigmentation | 0.50572008 |
| 119 | MP0005187_abnormal_penis_morphology | 0.50365862 |
| 120 | MP0010769_abnormal_survival | 0.50219995 |
| 121 | * MP0003956_abnormal_body_size | 0.50188456 |
| 122 | MP0000026_abnormal_inner_ear | 0.50082521 |
| 123 | MP0003861_abnormal_nervous_system | 0.50020033 |
| 124 | MP0004510_myositis | 0.48704891 |
| 125 | MP0010768_mortality/aging | 0.47082059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.62735988 |
| 2 | Myokymia (HP:0002411) | 6.44817737 |
| 3 | Focal seizures (HP:0007359) | 5.90322149 |
| 4 | Visual hallucinations (HP:0002367) | 5.64807011 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.57409398 |
| 6 | Hyperventilation (HP:0002883) | 5.14779593 |
| 7 | Atonic seizures (HP:0010819) | 4.93844663 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.77411178 |
| 9 | Absence seizures (HP:0002121) | 4.51029177 |
| 10 | Febrile seizures (HP:0002373) | 4.33757939 |
| 11 | Broad-based gait (HP:0002136) | 4.18468224 |
| 12 | Dialeptic seizures (HP:0011146) | 4.16597169 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.11538825 |
| 14 | Poor eye contact (HP:0000817) | 3.66431109 |
| 15 | Amblyopia (HP:0000646) | 3.47480329 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.38766951 |
| 17 | Impaired social interactions (HP:0000735) | 3.35721193 |
| 18 | Abnormal social behavior (HP:0012433) | 3.35721193 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.22564539 |
| 20 | Excessive salivation (HP:0003781) | 3.19453417 |
| 21 | Drooling (HP:0002307) | 3.19453417 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 3.17165474 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.11707535 |
| 24 | Action tremor (HP:0002345) | 3.08201501 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 3.05883604 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.02728198 |
| 27 | Anxiety (HP:0000739) | 3.02097294 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.01719227 |
| 29 | Insidious onset (HP:0003587) | 2.99111901 |
| 30 | Termporal pattern (HP:0011008) | 2.99111901 |
| 31 | Truncal ataxia (HP:0002078) | 2.97960439 |
| 32 | Depression (HP:0000716) | 2.91685322 |
| 33 | Dysmetria (HP:0001310) | 2.91146193 |
| 34 | Progressive inability to walk (HP:0002505) | 2.87043715 |
| 35 | EEG with generalized epileptiform discharges (HP:0011198) | 2.87008780 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.78577483 |
| 37 | Type II lissencephaly (HP:0007260) | 2.78454775 |
| 38 | Abnormality of the labia minora (HP:0012880) | 2.76357287 |
| 39 | Inability to walk (HP:0002540) | 2.75332361 |
| 40 | Limb dystonia (HP:0002451) | 2.74592139 |
| 41 | Ankle clonus (HP:0011448) | 2.70639553 |
| 42 | Hypsarrhythmia (HP:0002521) | 2.70217788 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.68367895 |
| 44 | Absent speech (HP:0001344) | 2.67329085 |
| 45 | Hemiparesis (HP:0001269) | 2.65311300 |
| 46 | Genetic anticipation (HP:0003743) | 2.63717642 |
| 47 | Congenital stationary night blindness (HP:0007642) | 2.63474188 |
| 48 | Postural instability (HP:0002172) | 2.61298212 |
| 49 | Pancreatic cysts (HP:0001737) | 2.60558736 |
| 50 | Torticollis (HP:0000473) | 2.59397004 |
| 51 | Status epilepticus (HP:0002133) | 2.59246208 |
| 52 | Focal dystonia (HP:0004373) | 2.57939745 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.56361235 |
| 54 | Diplopia (HP:0000651) | 2.56361235 |
| 55 | Stereotypic behavior (HP:0000733) | 2.55340998 |
| 56 | Protruding tongue (HP:0010808) | 2.52676711 |
| 57 | Mutism (HP:0002300) | 2.49783423 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.48951508 |
| 59 | Papilledema (HP:0001085) | 2.48724838 |
| 60 | Generalized myoclonic seizures (HP:0002123) | 2.48546606 |
| 61 | Nephronophthisis (HP:0000090) | 2.47562089 |
| 62 | True hermaphroditism (HP:0010459) | 2.47011696 |
| 63 | Scanning speech (HP:0002168) | 2.44969019 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.44326056 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.43026593 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.43026593 |
| 67 | Urinary urgency (HP:0000012) | 2.41439430 |
| 68 | Polyphagia (HP:0002591) | 2.39442511 |
| 69 | Bradykinesia (HP:0002067) | 2.39431442 |
| 70 | Abnormality of the lower motor neuron (HP:0002366) | 2.35890980 |
| 71 | Pheochromocytoma (HP:0002666) | 2.35733387 |
| 72 | Hypothermia (HP:0002045) | 2.34174681 |
| 73 | Gait imbalance (HP:0002141) | 2.31907815 |
| 74 | Spastic gait (HP:0002064) | 2.30694875 |
| 75 | Dysmetric saccades (HP:0000641) | 2.30005533 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.29770726 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.27610966 |
| 78 | Craniofacial dystonia (HP:0012179) | 2.24333329 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.23167560 |
| 80 | Pachygyria (HP:0001302) | 2.19394682 |
| 81 | Impaired vibratory sensation (HP:0002495) | 2.17581893 |
| 82 | Abnormality of the corticospinal tract (HP:0002492) | 2.15875687 |
| 83 | Blue irides (HP:0000635) | 2.15313992 |
| 84 | Delusions (HP:0000746) | 2.14279329 |
| 85 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.13562681 |
| 86 | Pendular nystagmus (HP:0012043) | 2.12507597 |
| 87 | Optic nerve hypoplasia (HP:0000609) | 2.11888853 |
| 88 | Abnormality of salivation (HP:0100755) | 2.09599947 |
| 89 | Hemiplegia (HP:0002301) | 2.07280539 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.06980243 |
| 91 | Resting tremor (HP:0002322) | 2.06976053 |
| 92 | Thyroid-stimulating hormone excess (HP:0002925) | 2.04836470 |
| 93 | Psychosis (HP:0000709) | 2.04609675 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02279063 |
| 95 | Failure to thrive in infancy (HP:0001531) | 2.01638946 |
| 96 | Generalized hypopigmentation of hair (HP:0011358) | 2.01058465 |
| 97 | Megalencephaly (HP:0001355) | 2.00722268 |
| 98 | Spastic tetraplegia (HP:0002510) | 2.00449652 |
| 99 | Incomplete penetrance (HP:0003829) | 1.99380372 |
| 100 | Decreased central vision (HP:0007663) | 1.97815732 |
| 101 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97512250 |
| 102 | Hypoplasia of the brainstem (HP:0002365) | 1.97500060 |
| 103 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.97500060 |
| 104 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.96609972 |
| 105 | Spastic tetraparesis (HP:0001285) | 1.96339758 |
| 106 | Lower limb muscle weakness (HP:0007340) | 1.94913000 |
| 107 | Specific learning disability (HP:0001328) | 1.94814453 |
| 108 | Fair hair (HP:0002286) | 1.93237153 |
| 109 | Gait ataxia (HP:0002066) | 1.92980873 |
| 110 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90313891 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89472222 |
| 112 | Intention tremor (HP:0002080) | 1.88960471 |
| 113 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.86680880 |
| 114 | Polydipsia (HP:0001959) | 1.86049786 |
| 115 | Abnormal drinking behavior (HP:0030082) | 1.86049786 |
| 116 | Abnormality of the renal cortex (HP:0011035) | 1.84020327 |
| 117 | Lower limb amyotrophy (HP:0007210) | 1.83936157 |
| 118 | Congenital primary aphakia (HP:0007707) | 1.83845345 |
| 119 | Annular pancreas (HP:0001734) | 1.83334883 |
| 120 | Severe muscular hypotonia (HP:0006829) | 1.83143382 |
| 121 | Dyskinesia (HP:0100660) | 1.82244599 |
| 122 | Attenuation of retinal blood vessels (HP:0007843) | 1.81975017 |
| 123 | Muscular hypotonia of the trunk (HP:0008936) | 1.81617563 |
| 124 | Hyperthyroidism (HP:0000836) | 1.79968803 |
| 125 | Agitation (HP:0000713) | 1.79296988 |
| 126 | Esotropia (HP:0000565) | 1.79248399 |
| 127 | Inappropriate behavior (HP:0000719) | 1.77007295 |
| 128 | Vaginal atresia (HP:0000148) | 1.76466741 |
| 129 | Akinesia (HP:0002304) | 1.76328717 |
| 130 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.75979439 |
| 131 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.75979439 |
| 132 | Genital tract atresia (HP:0001827) | 1.75795799 |
| 133 | Oligodactyly (hands) (HP:0001180) | 1.75734122 |
| 134 | Retinal dysplasia (HP:0007973) | 1.75470364 |
| 135 | Methylmalonic acidemia (HP:0002912) | 1.75372952 |
| 136 | Intellectual disability, severe (HP:0010864) | 1.73489583 |
| 137 | Cerebellar dysplasia (HP:0007033) | 1.73359359 |
| 138 | Lissencephaly (HP:0001339) | 1.73164571 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.72514642 |
| 140 | Cystic liver disease (HP:0006706) | 1.71639241 |
| 141 | Horizontal nystagmus (HP:0000666) | 1.70770103 |
| 142 | Rapidly progressive (HP:0003678) | 1.70036894 |
| 143 | Obstructive sleep apnea (HP:0002870) | 1.69961939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.03735289 |
| 2 | NTRK3 | 4.24773289 |
| 3 | MAP3K9 | 3.79037278 |
| 4 | CASK | 3.41212038 |
| 5 | MAP3K4 | 3.22515061 |
| 6 | MARK1 | 3.12112520 |
| 7 | MAP3K12 | 2.99703407 |
| 8 | MAP2K7 | 2.86382345 |
| 9 | FRK | 2.67538013 |
| 10 | DAPK2 | 2.64155493 |
| 11 | WNK3 | 2.48903034 |
| 12 | MINK1 | 2.46115707 |
| 13 | MAP4K2 | 2.41508053 |
| 14 | RIPK4 | 2.40110333 |
| 15 | PINK1 | 2.23002015 |
| 16 | MAP2K4 | 2.20154114 |
| 17 | NTRK2 | 1.92462140 |
| 18 | DAPK1 | 1.91490589 |
| 19 | PLK2 | 1.89777117 |
| 20 | TNIK | 1.79569476 |
| 21 | PNCK | 1.75689655 |
| 22 | PAK6 | 1.68187877 |
| 23 | DYRK2 | 1.68146383 |
| 24 | CDK19 | 1.63739620 |
| 25 | KSR2 | 1.63498827 |
| 26 | ADRBK2 | 1.62559681 |
| 27 | SIK2 | 1.61541205 |
| 28 | KSR1 | 1.58898675 |
| 29 | GRK5 | 1.57443473 |
| 30 | BMPR1B | 1.56941234 |
| 31 | PRPF4B | 1.51035779 |
| 32 | CAMKK1 | 1.49198634 |
| 33 | CDK5 | 1.44748891 |
| 34 | NTRK1 | 1.43418548 |
| 35 | FES | 1.38154619 |
| 36 | ERBB3 | 1.37988258 |
| 37 | MAPK13 | 1.33402247 |
| 38 | ARAF | 1.29506737 |
| 39 | MAP3K13 | 1.25243422 |
| 40 | BCKDK | 1.21121962 |
| 41 | PRKCG | 1.21109419 |
| 42 | BCR | 1.20055732 |
| 43 | GRK1 | 1.16324306 |
| 44 | ZAK | 1.15976357 |
| 45 | CAMK2A | 1.11923123 |
| 46 | CSNK1G3 | 1.10514436 |
| 47 | PRKD3 | 1.08341240 |
| 48 | PTK2B | 1.07587049 |
| 49 | CSNK1A1L | 1.04907916 |
| 50 | CAMKK2 | 1.04494301 |
| 51 | CSNK1G1 | 1.01954911 |
| 52 | BMPR2 | 0.99646698 |
| 53 | FGR | 0.97834094 |
| 54 | CAMK2B | 0.97107805 |
| 55 | TAOK3 | 0.94180861 |
| 56 | NUAK1 | 0.93189669 |
| 57 | INSRR | 0.90521669 |
| 58 | NME1 | 0.88758093 |
| 59 | OXSR1 | 0.88052016 |
| 60 | TYRO3 | 0.87809691 |
| 61 | STK38 | 0.84994564 |
| 62 | CCNB1 | 0.83593737 |
| 63 | SGK223 | 0.82973220 |
| 64 | SGK494 | 0.82973220 |
| 65 | CDK18 | 0.82252058 |
| 66 | CDK14 | 0.80826747 |
| 67 | PHKG2 | 0.80781518 |
| 68 | PHKG1 | 0.80781518 |
| 69 | STK11 | 0.79654742 |
| 70 | CDK15 | 0.78992684 |
| 71 | UHMK1 | 0.78790566 |
| 72 | WNK4 | 0.78380745 |
| 73 | LATS2 | 0.74477732 |
| 74 | CAMK1 | 0.74299731 |
| 75 | SGK2 | 0.73426321 |
| 76 | CSNK1G2 | 0.72402831 |
| 77 | SGK1 | 0.71177937 |
| 78 | DYRK1A | 0.69988775 |
| 79 | MAP3K2 | 0.68405354 |
| 80 | CDK11A | 0.67487802 |
| 81 | TRIM28 | 0.66927624 |
| 82 | GRK6 | 0.66416068 |
| 83 | PKN1 | 0.65306768 |
| 84 | RAF1 | 0.64972490 |
| 85 | MAPKAPK5 | 0.61358905 |
| 86 | LIMK1 | 0.61258230 |
| 87 | TLK1 | 0.61065026 |
| 88 | MAP3K6 | 0.60318900 |
| 89 | MKNK2 | 0.59714924 |
| 90 | PRKCE | 0.58306440 |
| 91 | PRKCH | 0.55533529 |
| 92 | PAK3 | 0.53959984 |
| 93 | RET | 0.53880568 |
| 94 | PRKCZ | 0.52376294 |
| 95 | MAPK12 | 0.52015095 |
| 96 | PDK1 | 0.50465519 |
| 97 | CAMK2D | 0.50418644 |
| 98 | MARK2 | 0.49043524 |
| 99 | CSNK1D | 0.48941808 |
| 100 | SGK3 | 0.48870002 |
| 101 | CSNK1A1 | 0.48446093 |
| 102 | SIK3 | 0.48390626 |
| 103 | DAPK3 | 0.46825869 |
| 104 | PDPK1 | 0.45807811 |
| 105 | FYN | 0.45011544 |
| 106 | TAOK1 | 0.44049796 |
| 107 | STK39 | 0.43952110 |
| 108 | AKT3 | 0.43250431 |
| 109 | MAP3K1 | 0.42418950 |
| 110 | RPS6KA3 | 0.39703333 |
| 111 | PRKCI | 0.39648363 |
| 112 | PRKG1 | 0.39468464 |
| 113 | RPS6KB1 | 0.39051100 |
| 114 | CAMK2G | 0.37480169 |
| 115 | MAP2K1 | 0.35855556 |
| 116 | PIK3CA | 0.35509021 |
| 117 | MUSK | 0.34909757 |
| 118 | MAPK10 | 0.34795655 |
| 119 | FER | 0.34647858 |
| 120 | MAP3K7 | 0.34387812 |
| 121 | CAMK4 | 0.33356238 |
| 122 | ADRBK1 | 0.33287944 |
| 123 | CAMK1G | 0.33156231 |
| 124 | TIE1 | 0.32598653 |
| 125 | PRKCB | 0.32130467 |
| 126 | PIM2 | 0.31414451 |
| 127 | ROCK2 | 0.31078522 |
| 128 | PRKACA | 0.29481819 |
| 129 | ACVR1B | 0.29426443 |
| 130 | ALK | 0.28813402 |
| 131 | RPS6KA5 | 0.28604349 |
| 132 | KIT | 0.28079262 |
| 133 | LMTK2 | 0.27342427 |
| 134 | GRK7 | 0.26320388 |
| 135 | MOS | 0.25953458 |
| 136 | MAP3K11 | 0.25821472 |
| 137 | PRKCA | 0.25610204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.19646902 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.37713652 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.95934114 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.82575827 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78973256 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.77945650 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76362678 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.68621802 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.66404277 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64836559 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31045903 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.17199146 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.94338273 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90910234 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90589471 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.89587336 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.89230110 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.87532029 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80215181 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78774164 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76216173 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.75730281 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.71583128 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68771857 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67736770 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62404175 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56070947 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37769983 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.33179790 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33065005 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32211425 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25343074 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24824780 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23981435 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18044935 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17492376 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.17106414 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16079936 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12743192 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09914987 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07105917 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06545933 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02776904 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01665181 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00425197 |
| 46 | Glioma_Homo sapiens_hsa05214 | 0.99969473 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.98721190 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98396657 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96214280 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95553405 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94993534 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94886532 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94708302 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.93497733 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93217538 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92060658 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87977481 |
| 58 | Protein export_Homo sapiens_hsa03060 | 0.81213108 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73935533 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73715274 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73516038 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72706352 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71710653 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69700313 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68985328 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68967564 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68640385 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68629164 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67013247 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64131383 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62910630 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62721898 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61241678 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60807221 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58761298 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58027078 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55749290 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55655445 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.54743938 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.52877480 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51969378 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51895953 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50279483 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49231390 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48635972 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48618884 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48302392 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48145424 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48004963 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47306968 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47078584 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45569160 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43430033 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.42908690 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.42333126 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41708991 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41517050 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40941131 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40764671 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40657812 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37339470 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.36645475 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35993597 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35567517 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35099286 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34732241 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34137042 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.33450842 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32210213 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31255279 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29691868 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29183100 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28237101 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.28193897 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28115761 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27729234 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27678111 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27654495 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26209338 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25566184 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.25487981 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.25270325 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.24782490 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23725099 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23406313 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21608095 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21438910 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20664244 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.20400446 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20102740 |

